Neurology: Volume 82, Number 10, March 11, 2014
About this course
- Released: 03/11/2014
- Expires: 03/11/2017
PRECREST: A PHASE II PREVENTION AND BIOMARKER TRIAL OF CREATINE IN AT-RISK HUNTINGTON DISEASE
LEARNING OBJECTIVES:
Upon completion of the article by Rosas et al, the participant should be able to:
- Briefly discuss the difference in dropout rates between groups
- List adverse effects associated with creatine
- Discuss the effect of creatine treatment on secondary study endpoints
CORE COMPETENCIES:
The article by Rosas et al covers the following core competency:
- Medical Knowledge
NEUROFASCIN IGG4 ANTIBODIES IN CIDP ASSOCIATE WITH DISABLING TREMOR AND POOR RESPONSE TO IVIG
LEARNING OBJECTIVES:
Upon completion of the article by Querol et al, the participant should be able to:
- Briefly discuss the function of neurofascin at the node of Ranvier
- Describe the distinct clinical phenotype of neurofascin IgG positive CIDP
- State the approximate frequency of IVIg-unresponsive CIDP
CORE COMPETENCIES:
The article by Querol et al covers the following core competency:
- Medical Knowledge
AUTHOR DISCLOSURES:
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
